Patents by Inventor Elizabeth E. SWEENEY

Elizabeth E. SWEENEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11993864
    Abstract: A method for forming a silicon carbide material with a plurality of negatively charged silicon mono-vacancy defects includes irradiating a silicon carbide sample, annealing the irradiated silicon carbide sample in an annealing operation, and quenching the annealed silicon carbide sample. Quenching may include heating the annealed silicon carbide sample to a maximum temperature and quenching the annealed silicon carbide sample to form the silicon carbide sample with the plurality of negatively charged silicon mono-vacancy defects.
    Type: Grant
    Filed: November 2, 2021
    Date of Patent: May 28, 2024
    Assignee: The Johns Hopkins University
    Inventors: John B. Abraham, Brian D. Clader, Robert Osiander, Cameron A. Gutgsell, Dalibor J. Todorovski, Scott A. Sperling, Jacob E. Epstein, Timothy M. Sweeney, Elizabeth A. Pogue, Tyrel M. McQueen
  • Patent number: 11931465
    Abstract: Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: March 19, 2024
    Assignee: Children's National Medical Center
    Inventors: Rohan Fernandes, Raymond W. Sze, Conrad Russell Y. Cruz, Anthony D. Sandler, Catherine M. Bollard, Elizabeth E. Sweeney, Juliana Cano-Mejia, Rachel Burga, Matthieu F. Dumont
  • Publication number: 20200163899
    Abstract: Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.
    Type: Application
    Filed: March 8, 2017
    Publication date: May 28, 2020
    Applicant: Children's National Medical Center
    Inventors: Rohan FERNANDES, Raymond W. SZE, Conrad Russell Y. CRUZ, Anthony D. SANDLER, Catherine M. BOLLARD, Elizabeth E. SWEENEY, Juliana CANO-MEJIA, Rachel BURGA, Mathieu F. DUMONT